CYTEK BIOSCIENCES INC (CTKB) Stock Cash Flow
NASDAQ:CTKB - Nasdaq - US23285D1090 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.02M | -12.15M | 2.48M | 3.03M | 19.41M | |||
| Depreciation Amortization | 10.49M | 9.23M | 2.49M | 1.24M | 600.00K | |||
| Income Taxes - Deferred | -2.89M | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 7.71M | -10.24M | -39.93M | -8.36M | -7.54M | |||
| Taxes Paid | 3.83M | 5.30M | 10.39M | 2.86M | 2.07M | |||
| Other non cash items | 16.08M | 18.44M | 22.72M | 8.72M | 2.68M | |||
| OPERATING CASH FLOW | 25.38M | 5.28M | -12.23M | 4.63M | 15.16M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -3.73M | -4.83M | -9.87M | -4.36M | -1.55M | |||
| Other Investing Activity | -79.25M | -89.07M | -46.04M | -16.63M | N/A | |||
| INVESTING CASH FLOW | -82.97M | -93.89M | -55.91M | -20.99M | -1.55M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 3.62M | -565.00K | 2.93M | -2.77M | 2.77M | |||
| Stock Issued/Repurchased | -18.89M | -40.83M | 2.79M | 216.33M | 119.84M | |||
| Other Financing Activity | -554.00K | -419.00K | -210.00K | N/A | N/A | |||
| FINANCING CASH FLOW | -15.82M | -41.81M | 5.51M | 213.56M | 122.61M | |||
| Exchange Rate Effect | 4.53M | -1.45M | -2.49M | 1.30M | -590.00K | |||
| CHANGE IN CASH | -68.89M | -131.87M | -65.12M | 198.50M | 135.63M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 25.38M | 5.28M | -12.23M | 4.63M | 15.16M | |||
| Capital Expenditure | -3.73M | -4.83M | -9.87M | -4.36M | -1.55M | |||
| FREE CASH FLOW | 21.65M | 454.00K | -22.10M | 270.00K | 13.61M | |||
All data in USD